MedPath

VARICO TRIAL, Prospective randomised trial to analyse short and long term results of stripping versus endovenous laser treatment of long saphenous vein incompetence under local anaesthesia.

Completed
Conditions
Recurrence of varicosis.Endovenous laser technique versus strippingLocal anaesthesiaTreatment of the long saphenous vein incompetence
Registration Number
NL-OMON25507
Lead Sponsor
Ab Aquapendente ResearchKoninginneweg 91217 KP Hilversum
Brief Summary

Eur J Vasc Endovasc Surg. 2010 Nov;40(5):649-56. <br><br> Randomised controlled trial comparing sapheno-femoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anaesthesia: one year results.<br> Pronk P, Gauw SA, Mooij MC, Gaastra MT, Lawson JA, van Goethem AR, van Vlijmen-van Keulen CJ. <br><br> Flebologisch Centrum Oosterwal, Overkrocht 10, 1815 KX Alkmaar, The Netherlands. pascalpronk888@hotmail.com. <br><br> Stefanie A. Gauw, CRC, James A. Lawson, MD, PhD, Clarissa J. van Vlijmen-van Keulen, MD, PhD, Pascal Pronk, MD, Menno T. W. Gaastra, MD, and Michael C. Mooij, MD. Five-year follow-up of a randomized, controlled trial comparing saphenofemoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anesthesia. Journal of vascular surgery. February 2016. Volume 63, Number 2: 420-428

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
274
Inclusion Criteria

1. Long saphenous vein (LSV) incompetence (duplex: reflux > 0,5 sec. measured and seen in standing position by manual compression or valsalva manouvre)

2. Diameter of LSV equal or more than 0,3 cm and equal or less than 1,5 cm

Exclusion Criteria

1. Patient does not meet the therefore mentioned inclusion criteria

2. Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary endpoint is the recurrence rate of the varicose vein.
Secondary Outcome Measures
NameTimeMethod
Secondary endpoints are complicatons and quality of life.
© Copyright 2025. All Rights Reserved by MedPath